Stay updated on Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial

Sign up to get notified when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page has been updated to reflect that it is currently active and not recruiting, with a new revision date of April 24, 2025, replacing the previous recruiting status and an earlier revision date of March 20, 2025.
    Difference
    2%
    Check dated 2025-04-30T14:23:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T10:38:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.
    Difference
    0.7%
    Check dated 2025-04-09T05:12:32.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study title regarding health-related quality of life in people with multiple myeloma has been updated to reflect a new date, changing from October 4, 2024, to March 20, 2025.
    Difference
    1%
    Check dated 2025-03-25T13:24:35.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:15:29.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:30:23.000Z thumbnail image

Stay in the know with updates to Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.